Science To Practice Group is fortunate to have the following Research Scientists with over 30 combined years of experience bringing Evidence-Based adolescent and emerging adult treatments to practice. 

Ashli Sheidow, Ph.D.

Dr. Sheidow has over 17 years of research on treatments for mental health and substance abuse problems in adolescents and emerging adults, particularly those who have co-occurring problems. Almost all of her  focus has included dissemination of evidence-based practices, in particular training practices for community-based counselors.

Dr. Sheidow’s research experience has focused broadly on the development, prevention, and treatment of adolescent and young adult psychopathology and delinquency from an ecological perspective, with concentrations in co-occurring disorders, effective dissemination of evidence-based practices, and advanced quantitative methods. Her research work, funded primarily by NIDA and NIMH, has included intervention development and evaluation projects, as well as dissemination and implementation research. She is on the editorial boards of the Journal of Child and Adolescent Substance Abuse and the Journal of Behavioral Health Services Research, and has led programming for national conferences on adolescent substance abuse research. 

Michael McCart, Ph.D. 

Dr. McCart is a clinical psychologist with specialized training in cognitive and behavioral approaches to treating serious clinical problems among youth and adults. He earned his Ph.D. in clinical psychology from the University of Wisconsin-Milwaukee.

Dr. McCart’s research experience focuses on enhancing intervention services for two high-risk clinical populations: (1) victims of interpersonal violence and (2) youth engaged in violent offending and/or substance use. His work with these groups, funded by NIMH, NIDA, and others, has spanned all phases of rigorous treatment research, including initial development and pilot testing of experimental intervention protocols, randomized efficacy studies, and multisite effectiveness trials.